BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25162970)

  • 1. Prediction of pathological complete response of breast cancer patients undergoing neoadjuvant chemotherapy: usefulness of breast MRI computer-aided detection.
    Kim H; Kim HH; Park JS; Shin HJ; Cha JH; Chae EY; Choi WJ
    Br J Radiol; 2014 Nov; 87(1043):20140142. PubMed ID: 25162970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-aided detection applied to breast MRI: assessment of CAD-generated enhancement and tumor sizes in breast cancers before and after neoadjuvant chemotherapy.
    Demartini WB; Lehman CD; Peacock S; Russell MT
    Acad Radiol; 2005 Jul; 12(7):806-14. PubMed ID: 16039534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of breast cancer on pre-treatment dynamic contrast-enhanced MRI using computer-aided detection is associated with response to neo-adjuvant chemotherapy.
    Chamming's F; Ueno Y; Aldis A; Seidler M; Mesurolle B; Omeroglu A; Gallix B; Reinhold C
    Diagn Interv Imaging; 2018 Dec; 99(12):773-781. PubMed ID: 30361133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A computer-aided diagnosis (CAD) scheme for pretreatment prediction of pathological response to neoadjuvant therapy using dynamic contrast-enhanced MRI texture features.
    Giannini V; Mazzetti S; Marmo A; Montemurro F; Regge D; Martincich L
    Br J Radiol; 2017 Aug; 90(1077):20170269. PubMed ID: 28707546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment Response Evaluation of Breast Cancer after Neoadjuvant Chemotherapy and Usefulness of the Imaging Parameters of MRI and PET/CT.
    An YY; Kim SH; Kang BJ; Lee AW
    J Korean Med Sci; 2015 Jun; 30(6):808-15. PubMed ID: 26028936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative dynamic breast magnetic resonance imaging kinetic features using computer-aided diagnosis: Association with survival outcome and tumor aggressiveness in patients with invasive breast cancer.
    Nam SY; Ko ES; Lim Y; Han BK; Ko EY; Choi JS; Lee JE
    PLoS One; 2018; 13(4):e0195756. PubMed ID: 29649266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Pathologic Response Evaluation Systems After Neoadjuvant Chemotherapy in Breast Cancers: Correlation With Computer-Aided Diagnosis of MRI Features.
    Choi WJ; Kim HH; Cha JH; Shin HJ; Chae EY
    AJR Am J Roentgenol; 2019 Oct; 213(4):944-952. PubMed ID: 31237439
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the Tumor Response After Neoadjuvant Chemotherapy in Breast Cancer Patients: Correlation Between Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathologic Tumor Cellularity.
    Choi WJ; Kim WK; Shin HJ; Cha JH; Chae EY; Kim HH
    Clin Breast Cancer; 2018 Feb; 18(1):e115-e121. PubMed ID: 28890184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer-aided evaluation of breast MRI for the residual tumor extent and response monitoring in breast cancer patients receiving neoadjuvant chemotherapy.
    Lyou CY; Cho N; Kim SM; Jang M; Park JS; Baek SY; Moon WK
    Korean J Radiol; 2011; 12(1):34-43. PubMed ID: 21228938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced MRI after neoadjuvant chemotherapy of breast cancer: lesion-to-background parenchymal signal enhancement ratio for discriminating pathological complete response from minimal residual tumour.
    Kim SY; Cho N; Shin SU; Lee HB; Han W; Park IA; Kwon BR; Kim SY; Lee SH; Chang JM; Moon WK
    Eur Radiol; 2018 Jul; 28(7):2986-2995. PubMed ID: 29380033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography.
    Park JS; Moon WK; Lyou CY; Cho N; Kang KW; Chung JK
    Acta Radiol; 2011 Feb; 52(1):21-8. PubMed ID: 21498321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Performances of breast magnetic resonance imaging in the context of neoadjuvant chemotherapy for breast cancer to predict pathological complete response].
    Brisson C; Diguisto C; Vildé A; Body G; Arbion F; Leveque J; Ouldamer L
    J Gynecol Obstet Hum Reprod; 2017 Feb; 46(2):147-154. PubMed ID: 28403971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic Heterogeneity of Breast Cancer Determined Using Computer-aided Diagnosis of Preoperative MRI Scans: Relationship to Distant Metastasis-Free Survival.
    Kim JY; Kim JJ; Hwangbo L; Suh HB; Kim S; Choo KS; Nam KJ; Kang T
    Radiology; 2020 Jun; 295(3):517-526. PubMed ID: 32228293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of CAD-generated tumor volumes measured using MRI in breast cancers before and after neoadjuvant chemotherapy.
    Takeda K; Kanao S; Okada T; Kataoka M; Ueno T; Toi M; Ishiguro H; Mikami Y; Togashi K
    Eur J Radiol; 2012 Oct; 81(10):2627-31. PubMed ID: 22221829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
    Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
    Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete response on MR imaging after neoadjuvant chemotherapy in breast cancer patients: Factors of radiologic-pathologic discordance.
    Choi WJ; Kim HH; Cha JH; Shin HJ; Chae EY; Yoon GY
    Eur J Radiol; 2019 Sep; 118():114-121. PubMed ID: 31439230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence rates after DCE-MRI image guided planning for breast-conserving surgery following neoadjuvant chemotherapy for locally advanced breast cancer patients.
    Garimella V; Qutob O; Fox JN; Long ED; Chaturvedi A; Turnbull LW; Drew PJ
    Eur J Surg Oncol; 2007 Mar; 33(2):157-61. PubMed ID: 17085007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer.
    Goorts B; Dreuning KMA; Houwers JB; Kooreman LFS; Boerma EG; Mann RM; Lobbes MBI; Smidt ML
    Breast Cancer Res; 2018 Apr; 20(1):34. PubMed ID: 29669584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in kinetic heterogeneity of breast cancer via computer-aided diagnosis on MRI predict the pathological response to neoadjuvant systemic therapy.
    Hwangbo L; Kim JY; Kim JJ; Lee NK; Kim S
    Eur Radiol; 2023 Jan; 33(1):440-449. PubMed ID: 35849178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applying a new quantitative global breast MRI feature analysis scheme to assess tumor response to chemotherapy.
    Aghaei F; Tan M; Hollingsworth AB; Zheng B
    J Magn Reson Imaging; 2016 Nov; 44(5):1099-1106. PubMed ID: 27080203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.